Loading stock data…
WAY
$18.69-0.70 (-3.61%)
Pre-Market$19.07+0.38 (+2.03%)· Last close May 13
Waystar Holding Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Waystar Holding Corp. in the Healthcare sector is trading at $18.69. Wall Street consensus targets $34.74 (23 analysts), implying a +85.9% move over the next 12 months. The stock is currently near its 52-week low of $18.62, remaining 40.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +85.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$18.69
Potential Downside
53%
Whystock Fair Value$8.79
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus23 analysts
Mean target$34.74+85.9%
Range$27.00 – $44.00
Fundamentals
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and reven...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.86B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
41.57
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.22%
Volume
Today's trading volume
2.48M
Recent News
Here’s Baron Discovery Fund’s Views on Waystar Holding Corp. (WAY)
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Discovery Fund”. A copy of the letter can be downloaded here. It was a difficult quarter for Baron Discovery Fund, both on an absolute and relative basis. The Fund declined 10.65% (Institutional Shares) in the quarter, compared to the Russell 2000 […]
Waystar Holding (WAY) Reports Q1 Adjusted EPS Above Estimates
Waystar Holding Corp. (NASDAQ:WAY) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts. On April 29, 2026, Waystar Holding Corp. (NASDAQ:WAY) reported Q1 adjusted EPS of $0.42, ahead of consensus estimates of $0.39, while revenue came in at $313.9 million versus expectations of $311.68 million. CEO Matt Hawkins said the […]
Waystar Holding Corp. Just Recorded A 17% EPS Beat: Here's What Analysts Are Forecasting Next
It's been a mediocre week for Waystar Holding Corp. ( NASDAQ:WAY ) shareholders, with the stock dropping 14% to...
Waystar Holding Corp (WAY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Waystar Holding Corp (WAY) reports a 22% revenue increase and highlights AI's role in expanding market opportunities.
Waystar Q1 Earnings Call Highlights
Waystar (NASDAQ:WAY) reported first-quarter 2026 results that management characterized as a “solid start to the year,” supported by platform expansion, strong bookings, and growing adoption of AI-embedded workflows across its healthcare revenue cycle offerings. Financial results: revenue up 22% and